The Food and Drug Administration (FDA), in co-sponsorship with American Association for Cancer Research (AACR) and American Society of Clinical Onocology (ASCO) is holding a Public Workshop entitle, “ Complexities in Personalized Medicine: Harmonizing Companion Diagnostics Across a Class of Targeted Therapies” The purpose of the workshop is to facilitate an in-depth discussion of harmonization of companion diagnostic devices across a class of targeted therapies. The workshop aims to foster collaborations in the clinical cancer research community; provide a deeper understanding of anticancer drug and device development related to personalized medicine; provide a unique perspective of personalized medicine; and help incorporate emerging scientific findings to harmonize companion diagnostics across a class of targeted therapies.
This public workshop will be held on March 24, 2015 beginning at 8:30 a.m. Eastern time and will be held at:
1127 Connecticut Avenue, NW
Washington, DC 20036
For additional information on this workshop and registration, please see the FDA/CDRH meeting/workshop website at:http://www.fda.gov/
MedicalDevices/NewsEvents/ WorkshopsConferences/ ucm436716.htm
Food and Drug Administration
Center for Devices and Radiological Health